<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00654524</url>
  </required_header>
  <id_info>
    <org_study_id>D8664L0001</org_study_id>
    <secondary_id>ChiCTR-TRC-00000068</secondary_id>
    <nct_id>NCT00654524</nct_id>
  </id_info>
  <brief_title>Randomized Study of Gonadotropin-releasing-hormone Agonist (GnRH-a) or Expectant Management for Endometriosis</brief_title>
  <official_title>A Randomized Study Comparing Goserelin or Expectant Management Following Laparoscopic Surgery for Advanced Endometriosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zhejiang University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to identify the recurrent rate and pregnancy rate of advanced
      endometriosis after laparoscopic surgery plus GnRHa goserelin acetate treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In order to decrease endometriosis recurrence and enhance pregnancy rate after surgical
      therapy, it has been proposed to use a post-surgical gonadotropin-releasing-hormone agonist
      (GnRHa) treatment. Data on the short-term recurrence of advanced endometriosis is rare.
      Although operative treatment has resulted in increasing pregnancy rate comparing non surgery
      management for moderate to severe endometriosis, very few data of spontaneous pregnancy rate
      are available comparing GnRHa treatment or expectant management after surgery treatment. In
      this situation, the investigators conduct a prospective, randomized, controlled study to
      determine whether postoperative GnRHa (goserelin acetate) therapy for advanced endometriosis
      is effective in reducing endometriosis recurrence rate and improving reproductive outcome.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2008</start_date>
  <completion_date type="Anticipated">December 2010</completion_date>
  <primary_completion_date type="Anticipated">December 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The recurrent rate of advanced endometriosis</measure>
    <time_frame>within one year after surgery or GnRH-a management</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The pregnancy rate following laparoscopic surgery for advanced endometriosis</measure>
    <time_frame>within one year after surgery or GnRH-a treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Endometriosis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm will be treated with goserelin depot-3.6mg plus add-back therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The patient with advanced endometriosis（stage III-IV）confirmed histologically after conservative laparoscopic surgery will be suggested to prepare for spontaneous pregnancy rather than any medical administration.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>gonadotropin-releasing-hormone agonist (GnRHa) - Goserelin</intervention_name>
    <description>The patient will be managed with GnRH-a injection (Goserelin 3.6mg) every 4 weeks for 6 months plus add-back therapy (Caltrate With Vitamin D 600mg p.o. q.d.&amp; Livial 1.25-2.5mg p.o. q.d.) if needed.</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Goserelin</other_name>
    <other_name>Caltrate With Vitamin D 600</other_name>
    <other_name>Livial</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;=18 years old

          -  Normal menstruation for 3 months before enrollment (25-35 days）

          -  Advanced endometriosis confirmed histologically (r-AFS score III-IV) with laparoscopy
             or laparotomy-pelvic pain and/or dysmenorrhea and/or dyspareunia

          -  Agreement on the strict follow-up plan

          -  Without previous hormonal treatment

          -  Using nonhormonal method of contraception during this study

        Exclusion Criteria:

          -  Serious heart diseases/pulmonary/liver/kidney diseases

          -  Previous non-endometriosis relevant surgery possibly influence to abdominal or pelvic
             pain

          -  Suspected malignancy in endometriosis

          -  Coagulation disorders with hemorrhagic tendency

          -  Pregnancy or lactation

          -  Allergy to GnRHa

          -  Previous ineffective treatment with GnRHa
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xinmei Zhang, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Women's Hospital School Of Medicine Zhejiang University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xinmei Zhang, Prof.</last_name>
    <phone>0086-571-87061501</phone>
    <phone_ext>2131</phone_ext>
    <email>zhangxinm@zju.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Women's Hospital School Of Medicine Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310006</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xinmei Zhang, Prof.</last_name>
      <phone>0086-571-87061501</phone>
      <phone_ext>2131</phone_ext>
      <email>zhangxinm@zju.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Xiufeng Huang, A/Prof.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 2, 2008</study_first_submitted>
  <study_first_submitted_qc>April 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2008</study_first_posted>
  <last_update_submitted>March 14, 2011</last_update_submitted>
  <last_update_submitted_qc>March 14, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 15, 2011</last_update_posted>
  <responsible_party>
    <name_title>XINMEI ZHANG</name_title>
    <organization>Women's Hospital School of Medicine Zhejiang University</organization>
  </responsible_party>
  <keyword>Endometriosis</keyword>
  <keyword>Recurrence</keyword>
  <keyword>Pregnancy Rate</keyword>
  <keyword>Laparoscopy</keyword>
  <keyword>Gonadotropin-Releasing Hormone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Hormones</mesh_term>
    <mesh_term>Goserelin</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>April 26, 2011</submitted>
    <returned>May 20, 2011</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

